Biochemical Changes in Erythrocytes as a Molecular Marker of Cell Damage during Long-Term Simvastatin Treatment.

Autor: Mikashinovich ZI; Department of General and Clinical Biochemistry No. 1, Rostov State Medical University, Ministry of Health of the Russian Federation, Rostov-on-Don, Russia., Belousova ES; Department of Pharmaceutical Chemistry and Pharmacology, Rostov State Medical University, Ministry of Health of the Russian Federation, Rostov-on-Don, Russia. belousovalena@mail.ru.
Jazyk: angličtina
Zdroj: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2016 Aug; Vol. 161 (4), pp. 600-3. Date of Electronic Publication: 2016 Sep 03.
DOI: 10.1007/s10517-016-3467-2
Abstrakt: Long-term administration of simvastatin to rats, irrespective of the baseline cholesterol levels, induced biochemical changes in erythrocytes attesting to hypoxic damage (accumulation of lactate and 2,3-diphosphoglycerate), disturbances in ATP-dependent mechanisms of ion homeostasis regulation (decrease in total ATPase and Ca(2+)-ATPase activities), and antioxidant enzymes system imbalance. These changes can be considered as a sensitive indicator and molecular basis of cell damage during long-term administration of statins.
Databáze: MEDLINE